Skip to content
★ Sign in to follow
TP

Theracour Pharma, Inc.

Shareholder
Related company / holding
Nanoviricides, Inc.
Total declarations
91
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (91 ops.)
€1.3M

Latest filing published 01 Feb 2013 for NANOVIRICIDES, INC., €14k.

Insider track record

Disclosed buys
0
Disclosed sells
91
Signal history

No signal scores available.

Theracour Pharma, Inc.: trading record in brief

Theracour Pharma, Inc. is a declared insider of Nanoviricides, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 16 December 2008 to 30 January 2013, the count stands at 91 filings.

The open-market record consists of 91 sales worth €1.3M, with no purchase. The totals do not cover 1 filing with an undisclosed amount. 2013 to date brings no purchases and 1 sale.

Most recently, on 1 February 2013, the filings show an open-market sale worth €14k in Nanoviricides, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Theracour Pharma, Inc.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations90 total

25 of 90 declarations